GSK plc under pressure: rebound rejected, decline stalling

GSK plc is in week 7 of a sell signal, and the technical picture over the last four weeks tells a choppy story. A capitulation week was followed by two sharp recovery sessions — buyers at 99% and 84% — before this week reversed firmly: sellers at 76%, CMF back negative, momentum deteriorating. The decline has yet to gain real traction, but the rebound was rejected right at the cluster of dynamic resistances in the 1928–1947 area.